Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jun 14, 2009; 15(22): 2731-2738
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2731
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2731
Precancerous lesions | Regression site n (%) | P-value | |
Celecoxib group | Placebo group | ||
Atrophy | 11/13 (84.6) | 7/13 (53.8) | 0.202 |
Metaplasia | 9/14 (64.3) | 9/18 (50) | 0.419 |
Atrophy + metaplasia1 | 3/4 (75) | 3/6 (50) | 0.895 |
Dysplasia | 35/39 (89.7) | 24/40 (60) | 0.002 |
-
Citation: Zhang LJ, Wang SY, Huo XH, Zhu ZL, Chu JK, Ma JC, Cui DS, Gu P, Zhao ZR, Wang MW, Yu J. Anti-
Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. World J Gastroenterol 2009; 15(22): 2731-2738 - URL: https://www.wjgnet.com/1007-9327/full/v15/i22/2731.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.2731